Stockchase Opinions

Stan Wong Ishares Trust S & P Global Healthcare Index IXJ-N PAST TOP PICK Nov 23, 2022

(A Top Pick Nov 24/21, Up 0.02%) Flat, but still beating the S&P by a wide margin. Likes healthcare, it's his 2nd or 3rd largest sector weighting right now. Solid names with both defensive and growth characteristics. Nice dividend, too.
N/A

Stock price when the opinion was issued

E.T.F.'s
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

COMMENT

Healthcare has been one of the spaces that has had very good earnings growth in the S&P and probably global as well. A very stable space. Probably a little bit of a stretch in terms of valuation. He tends to like some of the biotech names. Feels healthcare will continue to run because of the need to own something more secure and put into things that have a nice dividend. Very little volatility.

BUY

This is an interesting one and he has no problems with it. The one thing is that it is about 60% US, so it is not that much diversification on a global basis. Nothing wrong with that though.

TOP PICK
Healthcare has both defensive characteristics + growth attributes. Includes medical devices, pharma, medicare, biotechnology. Usually strong balance sheets with lots of cash, paving the way for higher dividends, share buybacks, and M&A activity. Aging population and growing middle class enhance prospects for healthcare. 70% is in US names. JNJ, PFE, Roche Holdings, ABT, UNH. Yield is about 1.1%.
BUY
His preference in the space. Basket of global healthcare names, and only a 40 bps MER.
BUY

Likes healthcare in general, a larger weight for him. Healthcare has been the leader YTD, only 11 days into the new year. Great, diversified way to own international and US names in the healthcare space. About 70% US, rest international. With healthcare, you get growth and defense. 42 bps.